ClinicalTrials.Veeva

Menu
M

Mississippi Retina Associates | Jackson, MS

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

AVD-104
Faricimab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) (SIGLEC)

Investigate the Safety, Pharmacokinetics, and Treatment effects of Single and Multi-dose of Intravitreal AVD-104 in participants with geographic atro...

Enrolling
Macular Degeneration
Geographic Atrophy of the Macula
Drug: AVD-104
Drug: Avacincaptad

This study will assess a pragmatic, treat and extend regimen of faricimab against the standard of a fixed dosing regimen.

Enrolling
Diabetic Macular Edema
Drug: Faricimab

Trial sponsors

A
McMaster University logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems